Previous Fox News host Tucker Carlson has moved his present to X after being fired, where he has conducted interviews with well-known people like former President Donald Trump and separate presidential candidate Robert F. Kennedy Jr.
Carlson released an episode titled” Trans, Inc” on October 4 that focused on providing transgender people with gender-affirming health care.
” Genital mutilation is not just a passing trend.” Learn the message on Carlson’s X blog sharing the show to learn more about the full-fledged business. The 48-minute video criticized transgender health maintenance practices like societal affirmation, surgery, and hormones. It compares” transsexuality” to “human sacrifice,” describing it as “unnatural” and “demented.” Carlson was no reachable for opinion.
Chris Mortiz was portrayed by Carlson in the movie as a “policy guy” who had “taken an in-depth investigative look at where the money is coming from.” Moritz has experience as a prosecutor, investment banker, and consultant, according to his scant online appearance. Mortiz did not respond when we asked for his opinion.
We have previously fact-checked some statements in the film. But here are three fresh claims about hormone therapy, gender-affirming procedures, and the transgender health care industry.
Moritz:” With regard to the trans pharmaceuticals, there are no peer-reviewed long-term studies that demonstrate the effectiveness or ineffectiveness of taking these extremely potent medications.”
It is untrue that Moritz claimed there was no studies at all. Some peer-reviewed articles on the hormone treatment of transgender people were published before to 1975, according to the Clinical Practice Guidelines of the ENDOCrine Society. More than 2000 articles about different facets of transgender treatment have since been published.
Numerous published and peer-reviewed studies looking at the long-term effects and effectiveness of cross-sex testosterone therapy on bone health, cardiovascular risk, deaths, mental functioning, and more were discovered by PolitiFact. There is enough research that we were able to identify systematic reviews—analyses of numerous independent studies studies—on particular facets of care, such as bone health.
Transgender adults have received hormonal therapy and sex reassignment surgery since the early 1970s, despite the fact that adolescent treatment for gender dysphoria did n’t begin until the late 1990s.
Also, non-transgender people, such as men with low testosterone and menopausal women, occasionally turn to hormone therapy.
According to the Endocrine Society’s Clinical Practice Guidelines, testosterone therapy for transgender men and women carries many of the same risks as gender hormone replacement therapy in people who are not gendered.
The recommendation outlines secure amounts and offers advice on how doctors should keep an eye out for potential side effects.
Carlson:” Female genital mutilation has n’t been brought up in the United States in a while. Is that as a result of our current formal engagement?
Female genital mutilation is a non-consensual treatment that may involve narrowing the vaginal opening or partially or completely removing the penis and labia minora. According to the World Health Organization, girls under the age of 15 are primarily subjected to it. In 30 African, Asian, and Middle Eastern nations, more than 200 million people have been impacted.
Physical work and pleasure are intended to be diminished or eliminated during the procedure. It is frequently regarded as a violation of human rights.
According to Dr. Marci Bowers, a obstetric surgeon who performs therapeutic surgeries for female genital mutilation victims as well as gender-affirming surgeries, the two procedures are completely different.
Barker stated that” Transgender procedure is done with complete acceptance of the individual.”
In non-medical and unsterile situations, female genital mutilation is typically required of girls under the age of 15. However, according to Bowers, chairman of the World Professional Association for Transgender Health, gender-affirming clinics are only occasionally carried out on patients under the age of 18, and are typically done in clinics by trained professionals. Only under the most serious problems of gender dysphoria, she said, is gender-affirming operation performed on minors.
Bowers also pointed out the differences between how the two procedures affect women’s sexual features, including their capacity for feeling or climax. In contrast to ( female genital mutilation ), which deprives a woman of functionality, gender-affirming clinics “are typically really beautiful therapies that leave the individual totally practical,” she said.
Marshall and Mariya Taher, co-founders of Sahiyo, a group working to finish female genital mutilation in Asia, concurred. According to Taher, PolitiFact” clearly” believes that gender-affirming health treatment does not equate to vaginal mutilation.
Taher expressed her sadness at the conflation of the two problems and the use of female genital mutilation as a cover to hurt and target trans youth and gender-differenced people.
Also, PolitiFact was informed by representatives from the End FGM network in the United States and Europe that gender-affirming surgeries and female genital mutilation are not the same.
Moritz:” The combined value profits of medical products and sex reassignment procedures in 2018 were$ 2.94 billion.” That amount had increased to$ 4.18 billion by 2022.
We are unaware of how Moritz arrived at those statistics because he provided no supporting data and did not respond to our questions.
We discovered a few market research studies that are readily available to the public. Buyers frequently order these reports when deciding whether to invest in particular sectors. However, without understanding the procedure behind them, it is challenging to judge the veracity of these reports, and estimates may differ greatly, according to experts.
Carlson made a more general claim that transgender health care is being driven by profits:” Transgenderism, it did n’t happen by accident,” he said. ” Some people are making money off of it.”
None of the 2022 business information we discovered for the United States increased to$ 4.18 billion, but some came near. For instance, according to Grand View Research, the market for U.S. sex reassignment hormone therapy will be worth$ 1.6 billion in 2022, while that for the surgical market will cost$ 2.1 billion.
According to Stephen Parente, professor of finance at the University of Minnesota Carlson School of Management, these principles can be determined by combining plan files, files from the federal and state governments, and knowledge directly from health providers. However, obtaining accurate quotes might be more difficult for treatments that are not covered by insurance. HealthCare claims that depending on the state and health plan, transgender individuals may not have the same access to health care services. Gov.
” Most forms of health care, including gender-affirming care,” include a variety of providers of goods and services, such as medications, medical appointments, hospital stays, etc. Melinda Butin, a teacher at the Bloomberg School of Public Health at Johns Hopkins, said. It is difficult to determine how much is spent on particular types of treatment in total because of this.
According to Supriya Munshaw, an associate professor at the Johns Hopkins Carey School of Business, the business size can vary depending on what is included in a specific measure. Is the doctor be a part of it or is it really operation? Issues, what about them? How do they decide which mastectomy procedures are performed for breast tumor and which are gender-affirming?
” How exactly are you figuring out the range?” remarked Munshaw. ” Unique research reports may have different findings.”
According to national data on regional health spending, the U.S. health care industry is already sizable and will reach$ 4.3 trillion in 2021. From an investment standpoint, a market of billions is” sizable market,” according to Munshaw, but “it does n’t mean that if something is profitable that the healthcare industry is pushing it.”
This report was written by PolitiFact scholar Caryn Baird.
